Prostate Cancer - oalib

OALib Journal期刊
ISSN: 2333-9721
费用：99美元

投递稿件

为什么选择我们？ >>

- 开源期刊

- 同行审议

- 快速出刊

- 终身存储

- 免费检索

- 免费推广

- 更多...

- 搜索引擎

Prostate Cancer

ISSN Print: 2090-3111

ISSN Online:

主页: http://www.hindawi.com/journals/pc/

分享:

Primary Zonal High Intensity Focused Ultrasound for Prostate Cancer: Results of a Prospective Phase IIa Feasibility Study

Roland Van Velthoven,Fouad Aoun,Ksenija Limani,Krishna Narahari,Marc Lemort,Alexandre Peltier

Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play

Nikhil Sapre,Luke A. Selth

Urologic Characteristics and Sexual Behaviors Associated with Prostate Cancer in an African-Caribbean Population in Barbados, West Indies

Anselm J. M. Hennis,Suh-Yuh Wu,Barbara Nemesure,M. Cristina Leske

Hypofractionated External-Beam Radiotherapy for Prostate Cancer

L. Chinsoo Cho,Robert Timmerman,Brian Kavanagh

Analysis of Preoperative Detection for Apex Prostate Cancer by Transrectal Biopsy

Tomokazu Sazuka,Takashi Imamoto,Takeshi Namekawa,Takanobu Utsumi

Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent

Timothy R. Rebbeck,Susan S. Devesa,Bao-Li Chang,Clareann H. Bunker

Blood Level Omega-3 Fatty Acids as Risk Determinant Molecular Biomarker for Prostate Cancer

Mishell Kris Sorongon-Legaspi,Michael Chua,Maria Christina Sio,Marcelino Morales

Androgen Receptor-Target Genes in African American Prostate Cancer Disparities

Bi-Dar Wang,Qi Yang,Kristin Ceniccola,Fernando Bianco

HMGB1: A Promising Therapeutic Target for Prostate Cancer

Munirathinam Gnanasekar,Ramaswamy Kalyanasundaram,Guoxing Zheng,Aoshuang Chen,Maarten C. Bosland,André Kajdacsy-Balla

The Role of Vascular Endothelial Growth Factor in Metastatic Prostate Cancer to the Skeleton

Emma Roberts,Davina A. F. Cossigny,Gerald M. Y. Quan

Emerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer

Jesal C. Patel,Benjamin L. Maughan,Archana M. Agarwal,Julia A. Batten,Tian Y. Zhang,Neeraj Agarwal

Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer

Henrique B. da Silva,Eduardo P. Amaral,Eduardo L. Nolasco,Nathalia C. de Victo,Rodrigo Atique,Carina C. Jank,Valesca Anschau,Luiz F. Zerbini,Ricardo G. Correa

Blood Level Omega-3 Fatty Acids as Risk Determinant Molecular Biomarker for Prostate Cancer

Mishell Kris Sorongon-Legaspi,Michael Chua,Maria Christina Sio,Marcelino Morales Jr.

Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play

Nikhil Sapre,Luke A. Selth

Variation in HNF1B and Obesity May Influence Prostate Cancer Risk in African American Men: A Pilot Study

Ganna Chornokur,Ernest K. Amankwah,Stacy N. Davis,Catherine M. Phelan,Jong Y. Park,Julio Pow-Sang,Nagi B. Kumar

Hypofractionated External-Beam Radiotherapy for Prostate Cancer

L. Chinsoo Cho,Robert Timmerman,Brian Kavanagh

Urologic Characteristics and Sexual Behaviors Associated with Prostate Cancer in an African-Caribbean Population in Barbados, West Indies

Anselm J. M. Hennis,Suh-Yuh Wu,Barbara Nemesure,M. Cristina Leske

Analysis of Preoperative Detection for Apex Prostate Cancer by Transrectal Biopsy

Tomokazu Sazuka,Takashi Imamoto,Takeshi Namekawa,Takanobu Utsumi,Mitsuru Yanagisawa,Koji Kawamura,Naoto Kamiya,Hiroyoshi Suzuki,Takeshi Ueda,Satoshi Ota,Yukio Nakatani,Tomohiko Ichikawa

Androgen Receptor-Target Genes in African American Prostate Cancer Disparities

Bi-Dar Wang,Qi Yang,Kristin Ceniccola,Fernando Bianco,Ramez Andrawis,Thomas Jarrett,Harold Frazier,Steven R. Patierno,Norman H. Lee

Advances in Robotic-Assisted Radical Prostatectomy over Time

Emma F. P. Jacobs,Ronald Boris,Timothy A. Masterson

3D versus 2D Systematic Transrectal Ultrasound-Guided Prostate Biopsy: Higher Cancer Detection Rate in Clinical Practice

Alexandre Peltier,Fouad Aoun,Fouad El-Khoury,Eric Hawaux,Ksenija Limani,Krishna Narahari,Nicolas Sirtaine,Roland van Velthoven

Skip Regulates TGF-β1-Induced Extracellular Matrix Degrading Proteases Expression in Human PC-3 Prostate Cancer Cells

Victor Villar,Jelena Kocic,Juan F. Santibanez

Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers

Diego J. Laderach,Lucas Gentilini,Felipe M. Jaworski,Daniel Compagno

Quantifying the Ki-67 Heterogeneity Profile in Prostate Cancer

Shane Mesko,Patrick Kupelian,D. Jeffrey Demanes,Jaoti Huang,Pin-Chieh Wang,Mitchell Kamrava

Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms

Joelle El-Amm,Ashley Freeman,Nihar Patel,Jeanny B. Aragon-Ching

A Pilot Study of Laparoscopic Doppler Ultrasound Probe to Map Arterial Vascular Flow within the Neurovascular Bundle during Robot-Assisted Radical Prostatectomy

Ketan K. Badani,Edan Y. Shapiro,William T. Berg,Sarah Kaufman,Ari Bergman,Chris Wambi,Arindam RoyChoudhury,Trushar Patel

Intake of Grains and Dietary Fiber and Prostate Cancer Aggressiveness by Race

Fred Tabung,Susan E. Steck,L. Joseph Su,James L. Mohler,Elizabeth T. H. Fontham,Jeannette T. Bensen,James R. Hebert,Hongmei Zhang,Lenore Arab

Recent Trends in Prostate Cancer Incidence by Age, Cancer Stage, and Grade, the United States, 2001–2007

Jun Li,Joseph A. Djenaba,Ashwini Soman,Sun Hee Rim,Viraj A. Master

Postoperative Radiotherapy after Radical Prostatectomy: Indications and Open Questions

Pirus Ghadjar,Daniel Zwahlen,Daniel M. Aebersold,F. Zimmermann

Laparoscopic Sentinel Lymph Node Biopsy for Prostate Cancer: The Relevance of Locations Outside the Extended Dissection Area

W. Meinhardt,H. G. van der Poel,R. A. Valdés Olmos,A. Bex,O. R. Brouwer,S. Horenblas

Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men

Pedro Fernandez,Charnita M. Zeigler-Johnson,Elaine Spangler,André van der Merwe,Mohamed Jalloh,Serigne M. Gueye,Timothy R. Rebbeck

Expression of Neutral Endopeptidase, Endothelin-1, and Nuclear Factor Kappa B in Prostate Cancer: Interrelations and Associations with Prostate-Specific Antigen Recurrence after Radical Prostatectomy

Panagiotis J. Vlachostergios,Foteini Karasavvidou,Grigorios Kakkas,George Moutzouris,Anna Patrikidou,Ioannis A. Voutsadakis,Danai D. Daliani,Elias Zintzaras,Michael D. Melekos,Christos N. Papandreou

Current Challenges in Development of Differentially Expressed and Prognostic Prostate Cancer Biomarkers

Steven M. Lucas,Elisabeth I. Heath

The Current Role of Androgen Deprivation in Patients Undergoing Dose-Escalated External Beam Radiation Therapy for Clinically Localized Prostate Cancer

Michael J. Smith,Naveed H. Akhtar,Scott T. Tagawa

Incidentally Found Prostate Cancer and Influence on Overall Survival after Radical Cystoprostatectomy

Algimantas Sruogis,Albertas Ulys,Giedre Smailyte,Zygimantas Kardelis,Arunas Kulboka,Giedre Anglickien？,Nerimantas Samalavicius,Marius Anglickis

Emerging Putative Biomarkers: The Role of Alpha 2 and 6 Integrins in Susceptibility, Treatment, and Prognosis

James R. Marthick,Joanne L. Dickinson

Markers of Field Cancerization: Proposed Clinical Applications in Prostate Biopsies

Kristina A. Trujillo,Anna C. Jones,Jeffrey K. Griffith,Marco Bisoffi

Long-Term (10-Year) Gastrointestinal and Genitourinary Toxicity after Treatment with External Beam Radiotherapy, Radical Prostatectomy, or Brachytherapy for Prostate Cancer

Grant K. Hunter,Chandana A. Reddy,Eric A. Klein,Patrick Kupelian,Kenneth Angermeier,James Ulchaker,Nabil Chehade,Andrew Altman,Jay P. Ciezki

Relationship of Dietary Intake of Omega-3 and Omega-6 Fatty Acids with Risk of Prostate Cancer Development: A Meta-Analysis of Prospective Studies and Review of Literature

Michael E. Chua,Maria Christina D. Sio,Mishell C. Sorongon,Jun S. Dy

Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer

Silvia Johansson,Lennart ？str？m,Fredrik Sandin,Ulf Isacsson,Anders Montelius,Ingela Turesson

Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells

Bin Han,Naohiro Fujimoto,Mizuki Kobayashi,Tetsuro Matsumoto

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity

David Thomson,Sophie Merrick,Ric Swindell,Joanna Coote,Kay Kelly,Julie Stratford,James Wylie,Richard Cowan,Tony Elliott,John Logue,Ananya Choudhury,Jacqueline Livsey

Histone Deacetylase Inhibitors Restore Cell Surface Expression of the Coxsackie Adenovirus Receptor and Enhance CMV Promoter Activity in Castration-Resistant Prostate Cancer Cells

Laura Kasman,Georgiana Onicescu,Christina Voelkel-Johnson

Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate Cancer

Helmut Bonkhoff

Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment

Teresa Maria Santos Amaral,Daniela Macedo,Isabel Fernandes,Luis Costa

Prostate Intrafraction Translation Margins for Real-Time Monitoring and Correction Strategies

Dale W. Litzenberg,James M. Balter,Scott W. Hadley,Daniel A. Hamstra,Twyla R. Willoughby,Patrick A. Kupelian,Toufik Djemil,Arul Mahadevan,Shirish Jani,Geoffrey Weinstein,Timothy Solberg,Charles Enke,Lisa Levine,Howard M. Sandler

Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry

Andrew M. McDonald,Justin M. Bishop,Rojymon Jacob,Michael C. Dobelbower,Robert Y. Kim,Eddy S. Yang,Heather Smith,Xingen Wu,John B. Fiveash

Risk Stratification after Biochemical Failure following Curative Treatment of Locally Advanced Prostate Cancer: Data from the TROG 96.01 Trial

Allison Steigler,James W. Denham,David S. Lamb,Nigel A. Spry

Growth and Progression of TRAMP Prostate Tumors in Relationship to Diet and Obesity

Melissa J. L. Bonorden,Michael E. Grossmann,Sarah A. Ewing,Olga P. Rogozina

©2008-2017 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705